Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifamycin SV MMX for Traveler's Diarrhea
NCT01142089Phase 3Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- May 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in traveler's diarrhea (TD) comparing Rifamycin SV MMX with Placebo (2 arms). Primary endpoint: Time to Last Unformed Stool at 24 hours. Started May 2010; status: completed.
02
Drugs
rifamycin SV-MMX
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT01142089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01142089.